NARI - Did Inari Medical (NARI) Buy Sales? Investor Lawsuit Claims Kickbacks Fueled Revenue – Hagens Berman | Benzinga

SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ:NARI) investors who suffered substantial losses to submit your losses now.

Class Period: Feb. 24, 2022 – Feb. 28, 2024
Lead Plaintiff Deadline: July 12, 2024
Visit: www.hbsslaw.com/investor-fraud/nari
Contact the Firm Now: NARI@hbsslaw.com
                                        844-916-0895

Inari Medical Class Action:

Inari Medical, a prominent medical device manufacturer, is currently navigating a protracted investigation initiated by the U.S. Department of Justice (DOJ). The inquiry centers around allegations of illegal kickbacks to healthcare professionals, casting a shadow over the company's reputation and financial stability.

The investigation came to light in late February, triggering a sharp decline in Inari's stock price and prompting a class-action lawsuit from concerned investors. On February 29, 2024, Inari disclosed that it had received a Civil Investigative Demand (CID) from the DOJ's Civil Division in December 2023. ...

NARI) Buy Sales? Investor Lawsuit Claims Kickbacks Fueled Revenue – Hagens Berman>Full story available on Benzinga.com